< 1 minute read
Jan. 17, 2022
Compound 17a: a SGK1 Inhibitor for Osteoarthritis
“compound 17a”
SGK1 kinase inhibitor preclinical activity in osteoarthritis explant model from DFG-out virtual screening, SBDD and MPO Journal of Medicinal Chemistry Sanofi, Frankfurt am Main, DE
Loading...
